Table 4 Aggregated AGREE II Scores across diseases [median(range)]
Priority diseases | Domains of AGREE II | |||||
|---|---|---|---|---|---|---|
| Â | Scope and purpose | Stakeholder involvement | Rigor of development | Clarity and presentation | Applicability | Editorial independence |
HIV (n = 10) | 57(19-78) | 43(22-58) | 16(6-30) | 88(33-94) | 22(0-58) | 4(0-29) |
Malaria (n = 11) | 71(19-89) | 38(6-53) | 20(6-32) | 88(17-97) | 15(0-52) | 0(0-25) |
Pre-eclampsia (n = 8) | 58(31-83) | 36(22-61) | 14(5-20) | 75(36-89) | 10(0-27) | 0(0-25) |
Diarrhoea in children (n = 7) | 58(25-83) | 36(22-58) | 14(6-20) | 83(42-100) | 10(0-27) | 4(0-25) |
Hypertension (n = 9) | 75(39-92) | 42(22-64) | 11(6-44) | 81(53-97) | 10(0-42) | 4(0-50) |
Overall | 58(19-92) | 39(6-75) | 14(5-44) | 83(17-100) | 10(0-58) | 0(0-50) |